ORGANIC COMPOUNDS
The invention relates to the use of compounds of formula (I) and edible salts thereof, wherein R1 is selected from the group consisting of 2-(1H-4-imidazolyl)-ethenyl, 1H-5-indolyl, 2-(1H-5- imidazolyl)-ethenyl, 1-amino-2-(1H-4-imidazolyl)-ethyl, (1,3-thiazol-2-yl)-ethenyl, 2,3-dihydro- 1H-indol-2-y...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to the use of compounds of formula (I) and edible salts thereof, wherein R1 is selected from the group consisting of 2-(1H-4-imidazolyl)-ethenyl, 1H-5-indolyl, 2-(1H-5- imidazolyl)-ethenyl, 1-amino-2-(1H-4-imidazolyl)-ethyl, (1,3-thiazol-2-yl)-ethenyl, 2,3-dihydro- 1H-indol-2-yl, 2-(pyrimidin-2-yl)ethenyl, heptadecanyl, 1-heptadec-8-enyl, heptadeca-8,11- dienyl, heptadeca-8,11,14-trienyl, 2-(4H-imidazol-2-yl)-ethenyl, 2-(4H-imidazol-2-yl)-ethyl, 2- phenyl-ethenyl, 2-(furan-2-yl)-ethenyl, 2-(thiophen-2-yl)-ethenyl, 2-(thiophen-3-yl)-ethenyl, 2- but-2-enoyl, 2-butyl, 2,6-dimethylhepta-1,5-dienyl, 1,3-benzothiazol-6-yl; R2 is selected from the group consisting of (1H-imidazol-4-yl)-methyl, (1H-3-indol-3-yl)- methyl, 4-hydroxybenzyl, methylsulfanylethyl, hydroxymethyl, CH2-COOH, (pyridin-4- yl)methyl, (pyridin-2-yl)methyl, 1-(2,6-dimethylhepta-1,5-dienyl), 2-(pyrimidin-2-yl)methyl, (1H- imidazol-5-yl)-methyl, (1H-imidazol-2-yl)-methyl, (1H-pyrrol-2-yl)-methyl, phenyl, pyrimidin-5- yl, pyrazin-2-yl; R3 is selected from the group consisting of H, COOH, or a compound selected from the group consisting of 3-(1H-imidazol-4-yl)prop-2-enamide, methyl 2,3-dihydro-1H-indole-2-carboxylate, and 3,6-bis[(1H-imidazol-4-yl)methyl]piperazine- 2,5-dione, as flavor modulating compound, and to flavor compositions and consumer products comprising said compounds.
L'invention concerne l'utilisation de composés de formule (I) et des sels comestibles de ceux-ci, où R1 est choisi dans le groupe constitué par 2-(1H-4-imidazolyl)-éthényl, 1H-5-indolyl, 2-(1H-5-imidazolyl)-éthényl, 1-amino-2-(1H-4-imidazolyl)-éthyl, (1,3-thiazol-2-yl)-éthényl, 2,3-dihydro-1H-indol-2-yl, 2-(pyrimidin-2-yl)éthényl, heptadécanyle, 1-heptadec-8-ényl, heptadéca-8,11-diényl, heptadéca-8,11,14-triényl, 2-(4H-imidazol-2-yl)-éthényl, 2-(4H-imidazol-2-yl)-éthyl, 2-phényl-éthényl, 2-(furan-2-yl)-éthényl, 2-(thiophén-2-yl)-éthényl, 2-(thiophén-3-yl)-éthényl, 2-but-2-énoyl, 2-butyl, 2,6-diméthylhepta-1,5-diényl, 1,3-benzothiazol-6-yl; R2 est choisi dans le groupe constitué par (1H-imidazol-4-yl)-méthyl, (1H-3-indol-3-yl)-méthyl, 4-hydroxybenzyle, méthylsulfanyléthyle, hydroxyméthyl, CH2-COOH, (pyridin-4-yl)méthyl, (pyridin-2-yl)méthyl, 1-(2,6-diméthylhepta-1,5-diényl), 2-(pyrimidin-2-yl)méthyl, (1H-imidazol-5-yl))-méthyl, (1H-imidazol-2-yl)-méthyl, (1H-pyrrol-2-yl)-méthyl, phényle, pyrimidin-5-yl, pyrazin-2-yl; R3 est choisi dans le groupe constitué par H, COOH, ou un composé choisi dans le gro |
---|